DuetteType I gNETsType I gastric neuroendocrine tumours (gNETs)UK tertiary centre
… (R0), recurrence and predictors of recurrence. EMR techniques (Duette vs inject & snare) were compared with Fisher’s exact test.Resul…
10,506articles mentioning drugs
58,393drug mentions
9,496distinct drugs extracted
0%of mentions human-reviewed
All extracted drugs
Showing 541–600 of 9,496, ordered by supporting articles. Choose a drug to see its evidence.
N-Acetyl Cysteine7PPIs7Streptozotocin7fondaparinux7high-dose corticosteroids7hydroxyurea7naltrexone7tyrosine kinase inhibitors7vaccines7SGLT-2i6Glipizide6BLV6Varenicline6Camrelizumab6Cancer Drugs6Benzene6Doxy-PEP6SGLT-2is6Aprepitant6DEX6Dostarlimab6T-DXd6Azacitidine6Esketamine6NAC6Fidaxomicin6ITM6Minocycline6N-acetylcysteine6pMDIs6NBCA6Clofazimine6Filgotinib6Ravulizumab6Atomoxetine6Methylphenidate6amoxicillin-clavulanate6Acetylcysteine6Triamcinolone6anti-PD16Nitrous oxide6Octreotide6injectate6IL-1β6Lenalidomide6OAC6Venetoclax6antihypertensive drugs6n-BCA6Anti-TNF6Golimumab6Placebo6aripiprazole6b/tsDMARDs6Lansoprazole6MDPV6Mitomycin C6Nalbuphine6PCSK9 inhibitors6Sodium-Glucose Co-Transporter 2 Inhibitors6
Articles mentioning drugs
10,506 articles · page 643 of 876HCVAlexandria Main University HospitalHCCcirrhosishepatocellular carcinoma
…ionally minimized the dominant carcinogenic effects of active HCV or HBV and cirrhosis-related disease progression, allowing a m…
Botoxachalasia spectrum disordersachalasia
…struction 12%, other 18%; 46% were previously treated patients (Botox, pneumatic dilatation, peroral endoscopic myotomy, or Heller’s …
PPISomerset NHS Foundation TrustBarrett’s OesophagusCFA
…09 patients were contacted via SMS who were known to have prior PPI use and a Kunzman score of >8 (high risk features for oesophage…
fluconazoleOesophageal candidiasisantifungal treatment
…rmed disease that were untreated. All treated patients received fluconazole, irrespective of disease severity. Investigation of potential p…
Budesonide orodispersible tabletsEosinophilic oesophagitis
…mediated condition requiring ongoing anti-inflammatory therapy. Budesonide orodispersible tablets (BOT) are licensed for induction and maintenance treatment, wit…
PEIpancreatic cancerPancreatic atrophyPERTPancreatic exocrine insufficiencypancreatic diseaseUK
…had FE-1 <200 µg/g, 5/21 (23.8%) had FE-1 <100 µg/g .Conclusion PEI prevalence varies substantially by pancreatic phenotype, being …
PERTPancreatic Enzyme Replacement Therapypancreatitischronic pancreatitisacute pancreatitisCPTranscutaneous Electrical Nerve StimulationAP
…5 (84%) patients were on Pancreatic Enzyme Replacement Therapy (PERT). 49 had a faecal elastase <20 (64%). 8 patients (10%) were see…
Faecal calprotectinulcerative colitisNHSIBDinflammatory bowel disease
…Introduction Faecal calprotectin (FC) is the standard noninvasive biomarker for monitoring infla…
rifampicinchronic liver diseasepersistent hepatocellular secretory failure (PHSF)hepatic malignancyPHSFpersistent hepatocellular secretory failurecholedocholithiasishepatocellular secretory failure
…ing PHSF).Shi M, Sheng L, Lian M, et al. Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure. J…
82.0%
glucocorticoidsrheumatoid arthritisSLEvasculitisankylosing spondylitistype 1 diabetescoeliac diseasehyperparathyroidism
…e cross-sectional analysis involving 300 IBD patients receiving glucocorticoids from a total of 1302 patients. Multivariable logistic regressio…
mesalazineUlcerative colitiscolorectal cancerCrohn’s diseaseCRCUCIBDinflammatory bowel diseasePSC
…with UC and IBD unclassified, only 68.2% (737/1080) were taking mesalazine. High-definition white light endoscopy was used in 50.2% of pro…